| MITJX | VSTSX | MITJX / VSTSX | |
| Total Expense Ratio | 0.38 | 0.01 | 3,800% |
| Annual Report Gross Expense Ratio | 0.38 | 0.01 | 3,800% |
| Fund Existence | 14 years | 9 years | - |
| Gain YTD | 10.933 | 16.247 | 67% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 5000000000 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 6.86B | 2.05T | 0% |
| Annual Yield % from dividends | 0.87 | 1.12 | 77% |
| Returns for 1 year | -5.53 | 12.13 | -46% |
| Returns for 3 years | 11.50 | 65.57 | 18% |
| Returns for 5 years | 10.35 | 76.60 | 14% |
| Returns for 10 years | 40.96 | N/A | - |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| CIGYX | 11.50 | 0.10 | +0.88% |
| AB Concentrated International Growth Adv | |||
| EPLDX | 23.89 | 0.18 | +0.76% |
| NYLI Epoch U.S. Equity Yield Class R6 | |||
| BSPAX | 801.98 | 2.40 | +0.30% |
| iShares S&P 500 Index Investor A | |||
| JMNCX | 13.06 | 0.03 | +0.23% |
| JPMorgan Research Market Neutral C | |||
| EMGAX | 33.22 | -0.02 | -0.06% |
| Allspring Emerging Markets Equity A | |||